Foghorn Therapeutics Inc.

Direct answer

Foghorn Therapeutics Inc. is publicly traded on NASDAQ under the ticker FHTX.

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing medicines. Their focus is on addressing genetically determined vulnerabilities within the chromatin regulatory system. The company employs its exclusive "Gene Traffic Control" platform to pinpoint, validate, and strategize drug development for specific targets within this complex system. Its pipeline...

Can you invest in Foghorn Therapeutics Inc.?

Yes. Foghorn Therapeutics Inc. trades publicly on NASDAQ as FHTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Foghorn Therapeutics Inc.

Detailed equity research is provided by MarketSnap.